1 November 2024 false No description of principal activity Taxfiler 2024.6 15213792 business:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 15213792 2024-10-31 15213792 2024-11-01 2025-10-31 15213792 business:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 15213792 business:FilletedAccounts 2024-11-01 2025-10-31 15213792 2025-10-31 15213792 business:Director1 2024-11-01 2025-10-31 15213792 2024-10-31 15213792 core:WithinOneYear 2025-10-31 15213792 core:WithinOneYear 2024-10-31 15213792 core:AfterOneYear 2025-10-31 15213792 core:AfterOneYear 2024-10-31 15213792 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-10-31 15213792 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-10-31 15213792 core:PreviouslyStatedAmount 2025-10-31 15213792 core:PreviouslyStatedAmount 2024-10-31 15213792 business:SmallEntities 2024-11-01 2025-10-31 15213792 countries:EnglandWales 2024-11-01 2025-10-31 15213792 2023-10-16 2024-10-31 iso4217:GBP xbrli:pure
Company Registration No. 15213792 (England and Wales)
Transcend Blood Consultation Ltd Unaudited accounts for the year ended 31 October 2025
Transcend Blood Consultation Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Transcend Blood Consultation Ltd Company Information for the year ended 31 October 2025
Director
Nathan Bevan
Company Number
15213792 (England and Wales)
- 3 -
Transcend Blood Consultation Ltd Statement of financial position as at 31 October 2025
2025
2024
Notes
£
£
Current assets
Cash at bank and in hand
310
650
Creditors: amounts falling due within one year
4
(250)
(200)
Net current assets
60
450
Total assets less current liabilities
60
450
Creditors: amounts falling due after more than one year
5
(233)
(572)
Net liabilities
(173)
(122)
Capital and reserves
Profit and loss account
(173)
(122)
Shareholders' funds
(173)
(122)
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 6 March 2026 and were signed on its behalf by
Nathan Bevan Director Company Registration No. 15213792
- 4 -
Transcend Blood Consultation Ltd Notes to the Accounts for the year ended 31 October 2025
1
Statutory information
Transcend Blood Consultation Ltd is a private company, limited by shares, registered in England and Wales, registration number 15213792.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Creditors: amounts falling due within one year
2025
2024
£
£
Accruals
250
200
5
Creditors: amounts falling due after more than one year
2025
2024
£
£
Taxes and social security
-
452
Loans from directors
233
120
233
572
6
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 5 -